Clinical Trials · NCT00909844

Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Ipsen
Enrollment
35
Start date
Apr 2008
Locations
10 sites, France
Primary endpoint
Percentage of Children With a Stabilisation or Regression of Tanner Pubertal Stage at the End of the Study (Final Visit), Compared to Pretreatment (Month -6) and Baseline (Month 0)
View Gonadorelin compound reference